infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 182 articles from: Hepatitis B

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Liver Stiffness Before Hepatitis C Treatment Predicts Liver Cancer Risk

    Hep Mag / 18 January 2021

  • Major hep B players Gilead and Vir join forces to find a cure

    Fierce Biotech / 18 January 2021

  • New tool to predict outcomes in cirrhosis of the liver

    Baylor College of Medicine / 11 November 2020

  • HCV-Related Liver Cancer Incidence Dropped in US Cohort

    Medscape / 28 September 2020

  • EASL recommendations on treatment of Hepatitis C 2020

    EASL / 28 September 2020

  • New method developed for non-invasive risk assessment following hepatitis C recovery

    Medical University of Vienna / 27 July 2020

  • Phase 1 clinical study begins for VTP-300 Immunotherapeutic for Hepatitis B patients

    Express Healthcare / 14 July 2020

  • Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection

    Assembly Biosciences press release / 14 July 2020

  • Gilead axes $445M Precision Biosciences gene therapy hep B pact

    Fierce Biotech / 14 July 2020

  • Racial inequalities in liver cancer deaths soared after launch of hepatitis C drugs

    Florida Atlantic University / 18 May 2020

← First12345...19Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • Treatment
      • HIV and HBV
      • HCV and HBV
      • Hepatitis delta
      • Living with HBV
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org